dozens-drugmakers-celebrate-new-year-raising-prices-hundreds-drugs

Three dozen drugmakers are raising prices on more than 250 prescription drugs, according to an analysis by RX Savings Solutions. The average price increase will be around 6.3%, although some drugs will see prices increase by 10% or more.

By contrast, the inflation rate in the U.S. for the 12 months through November is 2.2%.

The analysis, first reported by Reuters and the Wall Street Journal, also showed that the number of drugs seeing price increases as well as the average rate of increase are lower than in 2017, as Big Pharma faces pressure from President Trump and consumer groups alike to keep drug prices lower.

Allergan Plc raised prices on more than 50 drugs, with most of them rising by 9.5%, Reuters said, noting that Allergan maintains that the average list price of all drugs in its portfolio are rising by 3.8%. AbbVie Inc, meanwhile, increased the price of Humira, an arthritis treatment that is the words’ top-selling drug, by 6.2%.